Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record-based study
- PMID: 20530272
- PMCID: PMC2903328
- DOI: 10.1200/JCO.2009.25.6636
Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record-based study
Abstract
Purpose: Understanding delays in cancer diagnosis requires detailed information about timely recognition and follow-up of signs and symptoms. This information has been difficult to ascertain from paper-based records. We used an integrated electronic health record (EHR) to identify characteristics and predictors of missed opportunities for earlier diagnosis of lung cancer.
Methods: Using a retrospective cohort design, we evaluated 587 patients of primary lung cancer at two tertiary care facilities. Two physicians independently reviewed each case, and disagreements were resolved by consensus. Type I missed opportunities were defined as failure to recognize predefined clinical clues (ie, no documented follow-up) within 7 days. Type II missed opportunities were defined as failure to complete a requested follow-up action within 30 days.
Results: Reviewers identified missed opportunities in 222 (37.8%) of 587 patients. Median time to diagnosis in cases with and without missed opportunities was 132 days and 19 days, respectively (P < .001). Abnormal chest x-ray was the clue most frequently associated with type I missed opportunities (62%). Follow-up on abnormal chest x-ray (odds ratio [OR], 2.07; 95% CI, 1.04 to 4.13) and completion of first needle biopsy (OR, 3.02; 95% CI, 1.76 to 5.18) were associated with type II missed opportunities. Patient adherence contributed to 44% of patients with missed opportunities.
Conclusion: Preventable delays in lung cancer diagnosis arose mostly from failure to recognize documented abnormal imaging results and failure to complete key diagnostic procedures in a timely manner. Potential solutions include EHR-based strategies to improve recognition of abnormal imaging and track patients with suspected cancers.
Conflict of interest statement
Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Figures
References
-
- Goodson WH, III, Moore DH. Overall clinical breast examination as a factor in delayed diagnosis of breast cancer. Arch Surg. 2002;137:1152–1156. - PubMed
-
- Goodson WH, III, Moore DH. Causes of physician delay in the diagnosis of breast cancer. Arch Intern Med. 2002;162:1343–1348. - PubMed
-
- Kern KA. Medicolegal analysis of the delayed diagnosis of cancer in 338 cases in the United States. Arch Surg. 1994;129:397–403. - PubMed
-
- Kern KA. The delayed diagnosis of breast cancer: Medicolegal implications and risk prevention for surgeons. Breast Dis. 2001;12:145–158. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases